Skip to Content

Delaware Ivy Balanced Fund Class C IBNCX

Medalist Rating as of | See Macquarie Investment Hub
  • NAV / 1-Day Return 20.77  /  −0.19 %
  • Total Assets 1.5 Bil
  • Adj. Expense Ratio
    1.800%
  • Expense Ratio 1.800%
  • Distribution Fee Level Above Average
  • Share Class Type Level Load
  • Category Moderate Allocation
  • Investment Style Large Growth
  • Credit Quality / Interest Rate Sensitivity
  • Status Open
  • TTM Yield 1.36%
  • Turnover 82%

USD | NAV as of Apr 18, 2024 | 1-Day Return as of Apr 18, 2024, 12:17 AM GMT+0

Morningstar’s Analysis IBNCX

Will IBNCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Delaware Ivy Balanced Fund Class C's Average Process and People Pillar ratings are n't enough to prevent other weaknesses from sending this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IBNCX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 24.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Microsoft Corp

5.67 88.6 Mil
Technology

Amazon.com Inc

2.37 37.1 Mil
Consumer Cyclical

UnitedHealth Group Inc

2.31 36.2 Mil
Healthcare

NVIDIA Corp

2.30 36.0 Mil
Technology

Apple Inc

2.15 33.6 Mil
Technology

KKR & Co Inc Ordinary Shares

2.01 31.4 Mil
Financial Services

United States Treasury Notes 4.5%

1.99 31.1 Mil
Government

Vanguard Russell 2000 ETF

1.98 31.0 Mil

Costco Wholesale Corp

1.91 29.9 Mil
Consumer Defensive

HCA Healthcare Inc

1.90 29.8 Mil
Healthcare